NCT04253275View on ClinicalTrials.gov

Identification of Biomarkers in Ischemic Stroke - Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

November 24, 2020

Primary Completion Date

February 6, 2024

Study Completion Date

February 6, 2024

Conditions
Stroke, IschemicStroke Hemorrhagic
Interventions
GENETIC

blood samples

"Blood samples will be taken at inclusion, 12h, 24h, 48h, 7d, 3m and 1y for patients ; at inclusion, 3m and 1y for controls.~Microvesicles samples will be taken at inclusion, 7d and 3M ; at inclusion and 3M for controls."

DIAGNOSTIC_TEST

MRI without injection

MRI at inclusion for controls

Trial Locations (1)

Unknown

CHRU Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT04253275 - Identification of Biomarkers in Ischemic Stroke - Clinical Trial | Biotech Hunter | Biotech Hunter